Study Analyzes Socioeconomic Inequalities, Use of Smoking Cessation for COPD
June 21st 2018The progression of chronic obstructive pulmonary disease (COPD) can often be slowed with smoking cessation. However, among socioeconomically disadvantaged groups, many patients with COPD continue to smoke and have the lowest quit rates. A recent study investigated bupropion and varenicline and their use among different socioeconomic patterns.
New Rare Disease Program Addresses Patients' Challenges and Burdens
June 18th 2018Patients with rare diseases often face a difficult and long diagnosis and treatment process. Express Scripts recently announced a new Rare Conditions Care Value program that includes the introduction of a support service known as Second Opinion, which offers guidance and expert case review for patients on an individual basis, with PinnacleCare.
Studies Investigate Extent of Nontuberculous Mycobacterial Infections
June 13th 2018Nontuberculous mycobacteria (NTM) can result in pulmonary and extrapulmonary infections and are primarily acquired from environmental sources, including soil and water exposed surfaces. Recent studies investigated the risk factors of NTM infections and their prevalence among patients in the United States.
Which Factors Are Linked to Lower Risk of Lung Cancer in Patients With COPD?
June 13th 2018It is already known that patients with chronic obstructive pulmonary disease (COPD) face a greater risk of dying of lung cancer. According to new research, a concurrent asthma diagnosis and the use of inhaled corticosteroids may be associated with a decreased risk of lung cancer in patients with COPD, while the use of acetylsalicylic acid may be linked to an increased risk.
Physicians Assert Trust in Small Group Practices During Shift to Value-Based Care
June 12th 2018Physician migration from physician-led practices to hospital employment has shifted. While physicians working for a hospital or in a practice with some ownership increased by 32.6% in 2016, independent and physician led group practices reached 72% in 2017, according to a new Black Book report.
Updated Clinical Trial Results and Approval Progress for MS Ocrelizumab Treatment
June 8th 2018Ocrelizumab (Ocrevus) has been FDA approved for the treatment of primary progressive multiple sclerosis, and recent clinical trials with the anti-CD20 monoclonal antibody have revealed significant decreases in disease activity and disability progression in relapsing multiple sclerosis.
Two Studies Examine Death Records for Asthma Burden, Guideline Adherence by Providers
June 7th 2018Two recent studies examined issues related to asthma statistics and treatment: is mortality underrepresented due to how death certificates are recorded? How well do providers adhere to clinical guidelines for asthma?
Patients With Down Syndrome Have Higher Risk of Pulmonary Hemosiderosis
June 6th 2018Pulmonary hemosiderosis (PH) is a rare, chronic lung disease characterized by hemoptysis, iron deficiency anemia, and alveolar and/or interstitial opacities on lung imaging. Little about the etiology and pathophysiology of the disease is known, but PH typically involves periods of remission and relapse. New research that investigated the relationships between PH and Down syndrome (DS), and found that patients with DS have a higher risk of developing PH.
Study Examines Characteristics, Risk Factors of Depression in Early COPD
June 1st 2018Depression is one of the comorbidities of chronic obstructive pulmonary disease (COPD), but not much is known about the characteristics of depression in people with early COPD. A recent study indicated that patients with early COPD who had depression were more likely to have a lower quality of life, be females, live alone, and have a low income.
A Place-Based Approach May Help the US Implement Payment Reform
June 1st 2018Although accountable care organizations cover more than 32 million people in the United States, the financial savings have been limited and the outcomes are unknown. Place-based approaches aimed at integrating care, improving population health, and controlling costs may be beneficial to adopt as the United States moves away from mandatory participation in payment reform.
Study Analyzes Benefits of Ivacaftor Treatment for Cystic Fibrosis
May 30th 2018Patients with cystic fibrosis (CF) who were treated with ivacaftor have demonstrated favorable results for clinically important outcomes, including a lower prevalence of CF-related complications and improved lung function, according to a new study.
Interventions to Decrease Pediatric Hospital Readmission for Asthma Patients Are Not Effective
May 28th 2018While knowledge and care for children with asthma has increased over time, overall morbidity has not decreased. A new study evaluated which interventions were effective at the point of discharge from the hospital to prevent readmission.
Studies Evaluate Opioid and Preventive Treatment for Migraine
May 26th 2018Two study abstracts presented at the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting, in Baltimore, Maryland, examined the prevalence of preventive and opioid treatment for migraine.
Two Studies Evaluate Non-Tuberculous Mycobacterium Causes and Identification
May 25th 2018Non-tuberculous mycobacterium (NTM), a serious lung disease, can be identified in different ways in patients. Recently, 2 studies evaluated specific identification and causes of NTM in order to help predict treatment outcomes in the future.
BCBSA Announces Its Value-Based Care Program Outperforms Other Care Providers
May 23rd 2018Since the launch of the Blue Distinction Total Care program, it has outperformed 96% of industry quality measures in key healthcare quality and patient health metrics, The Blue Cross Blue Shield Association (BCBSA) announced.